Bambusa Therapeutics
unknown
unknown
Stage
About
Bambusa Therapeutics develops long-lasting bispecific antibodies for immune and inflammatory disorders.
Explore Bambusa Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.